Literature DB >> 3732385

Intranigral muscimol attenuates electrographic signs of seizure activity induced by intravenous bicuculline in rats.

D Garant, K Gale.   

Abstract

Rats were implanted with infusion cannulas in the substantia nigra (SN), and intracranial electrodes for recording the electroencephalogram (EEG). These rats received intravenous injections of bicuculline, producing repetitive high voltage spike-and-wave complexes. Pretreatment with bilateral intranigral infusions of the GABA agonist muscimol reduced the duration of EEG epileptic activity by over 80%, as compared to the effect of pretreatment with intranigral saline in the same rats. This antiepileptic effect of intranigral muscimol may reflect a primary influence of SN outputs on brain excitability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732385     DOI: 10.1016/0014-2999(86)90242-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The expression of GABA(A) receptor subunits in the substantia nigra is developmentally regulated and region-specific.

Authors:  J Velísková; H Kubová; L K Friedman; R Wu; E F Sperber; R S Zukin; S L Moshé
Journal:  Ital J Neurol Sci       Date:  1998-08

Review 2.  The role of the brain stem in generalized epileptic seizures.

Authors:  C L Faingold
Journal:  Metab Brain Dis       Date:  1987-06       Impact factor: 3.584

3.  Effect of intranigral dosage with delta-sleep-inducing peptide and its analogs on movement and convulsive activity in rats.

Authors:  A A Shandra; R S Godlevskii; A I Vast'yanov; A I Brusentsov; I I Mikhaleva; I A Prudchenko; V N Zaporozhan
Journal:  Neurosci Behav Physiol       Date:  1996 Nov-Dec

4.  Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices.

Authors:  M Kokaia; P Aebischer; E Elmér; J Bengzon; P Kalén; Z Kokaia; O Lindvall
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.